Literature DB >> 29360890

Lichen planus pemphigoides treated with ustekinumab.

Raymond R Knisley1, Angelo A Petropolis2, Vernon T Mackey3.   

Abstract

A 71-year-old woman presented with pink to violaceous, flat-topped, polygonal papules on the volar wrists, extensor elbows, and bilateral lower legs of 3 years' duration. She also had erythematous, violaceous, infiltrated plaques with microvesiculation on the bilateral thighs of several months' duration. She reported pruritus, burning, and discomfort. Her medical history included type 2 diabetes mellitus, hypertension, and asthma with no history of skin rashes. Workup revealed lichen planus pemphigoides (LPP), a rare papulosquamous and vesiculobullous dermatosis that shares features of both lichen planus (LP) and bullous pemphigoid (BP). Despite multiple traditional therapies, her disease continued to progress, further developing mucosal disease. After a review of the literature on LP, BP, and LPP, it was noted that tumor necrosis factor α (TNF-α), along with other cytokines, plays a pivotal role in all 3 diseases. After several conventional systemic therapies failed, we treated our patient with ustekinumab with favorable results.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29360890

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  3 in total

1.  The clinical evolution of lichen planus pemphigoides.

Authors:  Mahmud Alkul; Jay Truitt; Michelle B Tarbox
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-02-04

2.  Treatment of lichen planus pemphigoides with mesalamine: novel use of this drug.

Authors:  Vijay Gandhi; Pradeep Kumar; Ankita Chauhan
Journal:  An Bras Dermatol       Date:  2022-09-06       Impact factor: 2.113

Review 3.  Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering.

Authors:  Franziska Hübner; Ewan A Langan; Andreas Recke
Journal:  Front Immunol       Date:  2019-07-02       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.